Covestor’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
Other funds holding IRON
Covestor's IRON Position: Q3 2026 in Review
Covestor reduced its Disc Medicine (IRON) stake by 43% in Q3 2026, selling an estimated $227 and leaving 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2595.
Covestor first reported a position in IRON in Q3 2023 and has held it in 13 quarters since. The position peaked at $1K in Q2 2026. 234 funds tracked by Wall St. Rank hold IRON as of Q3 2026.
- Covestor held 4 shares of Disc Medicine worth $0 as of Q3 2026.
- Covestor sold 3 Disc Medicine shares in Q3 2026, an estimated $227.
- Disc Medicine made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2595 holding.
- Covestor first reported a position in Disc Medicine in Q3 2023 and has held it in 13 quarters since.
- Covestor's Disc Medicine position peaked at $1K in Q2 2026.
- 234 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.